Investment Counsel’s AbbVie ABBV Stock Holding History

Investment Counsel’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-4,000	Closed	-$248K	–	62
2016 Q2	$248K	Buy	+4,000	New	+$244K	0.2%	63

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Investment Counsel's ABBV Position: Q3 2016 in Review

Investment Counsel sold out of AbbVie (ABBV) in Q3 2016, closing a stake of 4,000 shares — an estimated $248K sold.

Investment Counsel first reported a position in ABBV in Q2 2016 and held it in 1 quarter. The position peaked at $248K in Q2 2016. 1,653 funds tracked by Wall St. Rank hold ABBV as of Q3 2016.

Investment Counsel reported no remaining AbbVie position as of Q3 2016 after selling out during the quarter.
Investment Counsel sold 4,000 AbbVie shares in Q3 2016, an estimated $248K.
Investment Counsel first reported a position in AbbVie in Q2 2016 and held it in 1 quarter.
Investment Counsel's AbbVie position peaked at $248K in Q2 2016.
1,653 funds tracked by Wall St. Rank held AbbVie as of Q3 2016.

Based on Investment Counsel's 13F filing for Q3 2016, filed 10 Nov 2016.